Posted on 26/09/2017
Rayner announced today it’s schedule of events and opportunities for surgeons during the upcoming ESCRS Congress, on the Rayner booth #P207 (Pavilion 2), which includes the launch of the RayOne Trifocal IOL and a preview of the RayOne Hyd...
Posted on 22/09/2017
For those of you who have visited the Rayner website over the last few days, you will have noticed we’re now offering a very different online experience; one that we believe is clearer and more user-friendly.
It’s al...
Posted on 14/09/2017
14 September, 2017. Rayner are proud to announce the launch of the newest member of the RayOne® family of preloaded IOLs: the RayOne&re...
Posted on 7/09/2017
With a large part of 2016 and 2017 focused on European expansion, Rayner announced today its investment into the US market with the establishment of a dedicated subsidiary, ‘Rayner Surgical Inc.’
Based out of New York, Rayner S...
Posted on 11/07/2017
Rayner announced today the latest update in the RayOne story: registration of the RayOne Aspheric and Spheric monofocal fully preloaded IOL injection systems has been listed in the Federal Register by ANVISA, the Brazilian National Sanitary Sur...
Posted on 19/06/2017
An experimental study was recently conducted to compare current fully preloaded intraocular lens (IOL) injection systems on the market.
The study explored wound architecture after IOL implantation and the overall ease and speed...
Posted on 24/04/2017
Rayner will mark an important milestone next month: the 10-year anniversary of US Food and Drug Administration (FDA) approval of C-flex 570C monofocal Intraocular Lens (IOL) for commercial use in the United States of Ame...
Posted on 27/02/2017
March 02, 2017 – Worthing, United Kingdom. Rayner announced today that a selection of models in their Sulcoflex range of pseudophakic supplementary IOLs have received Chi...
Posted on 15/02/2017
In 2016, 773 Rayner IOLs were used to restore the sight of some of Bangladesh’s poorest and most isolated people, according to the recent Annual IMPACT partner report. There were no complications found during post-operative follow up visi...
Posted on 31/01/2017
Phoenix Equity Partners ("Phoenix"), a leading UK middle-market private equity firm, today announces an investment in Rayner Surgical Group (“Rayner” or “the Company”) alongside the current management team...